The weak evidence that leptin is inversely associated with overall prostate cancer risk reflects the findings of the Mendelian randomisation analysis of weak evidence of an association of BMI with lower prostate cancer risk10, but it is not possible to know whether the association of BMI is mediated by leptin or leptin is purely a marker for high BMI. This evidence concerns the gene LEP and Familial prostate cancer.